Serina Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Serina Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Serina Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -201 %, a 466% decline year-over-year.
  • Serina Therapeutics, Inc. annual Return On Assets for 2023 was -129 %, a 67.6% increase from 2022.
  • Serina Therapeutics, Inc. annual Return On Assets for 2022 was -397 %, a 29% decline from 2021.
  • Serina Therapeutics, Inc. annual Return On Assets for 2021 was -308 %, a 27.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -201 -166 -466% Apr 1, 2024 Jun 30, 2024
Q1 2024 -234 -114 -95.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -129 +268 +67.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56 +323 +85.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -35.6 +312 +89.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -120 +223 +65.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -397 -89.3 -29% Oct 1, 2022 Dec 31, 2022
Q3 2022 -379 -81.9 -27.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -347 -70.8 -25.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -343 -99.5 -40.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -308 -65.8 -27.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -297 -90.3 -43.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -276 -164 -147% Apr 1, 2021 Jun 30, 2021
Q1 2021 -243 -85.8 -54.4% Jan 1, 2021 Mar 31, 2021
Q4 2020 -242 -115 -90% Oct 1, 2020 Dec 31, 2020
Q3 2020 -207 -85.2 -69.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -112 Apr 1, 2020 Jun 30, 2020
Q1 2020 -158 Jan 1, 2020 Mar 31, 2020
Q4 2019 -127 Oct 1, 2019 Dec 31, 2019
Q3 2019 -122 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.